Quick Answer
Olive Leaf Extract Blood Pressure Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: The declining CVD mortality rate that was observed remained stable in the last years or even increased in some populations [,].
Key Takeaways
- 01The declining CVD mortality rate that was observed remained stable in the last years or even increased in some populations [,]. [Lauwers Stef (2026)]
- 025 6 7 8 Poor management of factors, such as diet, physical activity, blood lipids, and blood pressure, will increase the risk of developing CVD as a 20 mmHg increase in systolic blood pressure (SBP) is associated with a doubled risk of death from CVD [,]. [Lauwers Stef (2026)]
- 03CVD risk factors often occur clustered, as hypertension is linked to dyslipidaemia, impaired glucose tolerance and type 2 diabetes [,]. [Lauwers Stef (2026)]
- 041 2 3 4 Over the past few decades, remarkable progress has been made in developing strategies to lower the incidence of cardiovascular diseases (CVD). [Lauwers Stef (2026)]
The current Migaku evidence database contains 2 reusable source documents for Olive Leaf Extract Blood Pressure Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- The declining CVD mortality rate that was observed remained stable in the last years or even increased in some populations [,]. [Lauwers Stef (2026); evidence level 2]
- 5 6 7 8 Poor management of factors, such as diet, physical activity, blood lipids, and blood pressure, will increase the risk of developing CVD as a 20 mmHg increase in systolic blood pressure (SBP) is associated with a doubled risk of death from CVD [,]. [Lauwers Stef (2026); evidence level 2]
- CVD risk factors often occur clustered, as hypertension is linked to dyslipidaemia, impaired glucose tolerance and type 2 diabetes [,]. [Lauwers Stef (2026); evidence level 2]
- 1 2 3 4 Over the past few decades, remarkable progress has been made in developing strategies to lower the incidence of cardiovascular diseases (CVD). [Lauwers Stef (2026); evidence level 2]
- It is widely promoted for weight management, reduction in risk factors for developing common chronic diseases, and longevity support [,,]. [Szlapinski Sandra K. (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources